Wardwizard Healthcare has scheduled a meeting of its Board of Directors for Monday, August 31, 2026. The primary agenda includes considering proposals for raising further capital and increasing the authorized share capital.

The company intends to discuss the creation, offer, issue, and allotment of equity shares and equity-linked instruments. This may include convertible preference shares, non-convertible debt instruments with warrants, fully or partly convertible debentures, Global Depository Receipts, American Depository Receipts, and Foreign Currency Convertible Bonds.

Capital Raising Modes

The proposed capital raising can occur through public or private offerings, qualified institutional placements, preferential allotments, or other permissible modes under applicable laws. Any such issuance will require shareholder approval at an ensuing General Meeting and relevant regulatory approvals.

In addition to the capital raise, the Board will consider an increase in the authorized share capital and consequential alterations to Clause V of the Memorandum of Association.

Trading Window Closure

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities is closed for all Designated and Connected persons and their immediate relatives. This closure began on August 24, 2026, and will remain in effect until 48 hours after the announcement of the Board Meeting outcome.

The intimation was issued under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rajbala Kiroriwal, Company Secretary and Compliance Officer, signed the communication.

Wardwizard Healthcare Limited has released its unaudited standalone financial results for the first quarter of FY27, covering the period ended June 30, 2026. The filing was published in newspapers including Financial Express and Pratahkal on August 15, 2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

For the quarter ended June 30, 2026, the company recorded total operating revenue from ordinary activities of ₹1,535.41 crore. This figure remains unchanged compared to the corresponding period in the previous fiscal year, which also reported ₹1,535.41 crore.

The net profit after tax for the quarter stood at ₹73.51 crore, excluding extraordinary items. In the same period last year, the net profit was ₹220.46 crore. The earnings per share (EPS) for the current quarter were reported at ₹2.01, a decline from ₹6.04 in the prior year's comparable period.

Regulatory Disclosures

The results were approved by the Board of Directors during its meeting held on August 14, 2026. The company confirmed that the financial statements are available on its website, wardwizardhealthcare.com, as per Regulation 46 of the Listing Regulations. The filing references Regulation 47 and Regulation 30 of the SEBI LODR Regulations, 2015.